$19.60
-0.33-1.66%
Pre-Market: Feb 4, 7:07 AM EDT
Singular Genomics Sys reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Singular Genomics Sys using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-6.72 | $-7.86 | 14.5 % |
Q2 | 2024-08-13 | $-8.57 | $-8.88 | 3.49 % |
Q1 | 2024-05-14 | $-10.20 | $-10.50 | 2.86 % |
Q4 | 2024-03-18 | $-9.60 | $-10.20 | 5.88 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $406.00K | $825.00K | -50.8 % |
Q2 | 2024-08-13 | $737.00K | $400.00K | 84.3 % |
Q1 | 2024-05-14 | $442.00K | $390.00K | 13.3 % |
Q4 | 2024-03-18 | $1.08M | $730.00K | 48.1 % |
Singular Genomics Sys (OMIC) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-6.72, which beat the estimate of $-7.86.
The Actual Revenue was $406K, which missed the estimate of $825K.
Browse earnings estimates, EPS, and revenue on all stocks.